Literature DB >> 11749698

The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice.

A Minagawa1, Y Otani, T Kubota, N Wada, T Furukawa, K Kumai, K Kameyama, Y Okada, M Fujii, M Yano, T Sato, A Ito, M Kitajima.   

Abstract

The flavonoid nobiletin (5,6,7,8,3',4'-hexamethoxyflavone), found in Citrus depressa Rutaceae, a popular citrus fruit in Okinawa, Japan, reportedly inhibits the production of pro-matrix metalloproteinase (proMMP)-1, 3, and 9 in rabbit synovial fibroblasts in vitro. In the present study, we demonstrated the inhibitory effects of nobiletin on the proliferation of the cancer cell line, TMK- 1, and its production of MMPs. In the SCID mouse model, we found that nobiletin inhibited the formation of peritoneal dissemination nodules from TMK-1. The enzymatic activity of MMP-9 expressed in culture medium obtained from a co-culture of TMK-1 and mouse fibroblastic cells was inhibited by nobiletin in a concentration-dependent manner. In the SCID mouse model, total weight of dissemination nodules was significantly lower in the treated group compared with the vehicle control group (0.07 g vs. 0.78 g, P = 0.0059). The total number of dissemination nodules was also significantly lower than in the vehicle control group (7.5 vs. 69.3 / body, P = 0.0001). These results suggest that nobiletin may be a candidate anti-metastatic drug for prevention of peritoneal dissemination of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11749698      PMCID: PMC5926678          DOI: 10.1111/j.1349-7006.2001.tb02156.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  35 in total

1.  Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma.

Authors:  P D Brown; R E Bloxidge; N S Stuart; K C Gatter; J Carmichael
Journal:  J Natl Cancer Inst       Date:  1993-04-07       Impact factor: 13.506

Review 2.  Antimutagens and anticarcinogens in foods.

Authors:  B Stavric
Journal:  Food Chem Toxicol       Date:  1994-01       Impact factor: 6.023

3.  Inhibition of cyclic AMP phosphodiesterase by flavonoids.

Authors:  T Nikaido; T Ohmoto; U Sankawa; T Hamanaka; K Totsuka
Journal:  Planta Med       Date:  1982-11       Impact factor: 3.352

4.  Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1.

Authors:  A Ochiai; W Yasui; E Tahara
Journal:  Jpn J Cancer Res       Date:  1985-11

5.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

Authors:  H Sano; Y Kawahito; R L Wilder; A Hashiramoto; S Mukai; K Asai; S Kimura; H Kato; M Kondo; T Hla
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

6.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

Authors:  M Tsujii; S Kawano; R N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

7.  Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

Authors:  H Sato; M Seiki
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

8.  Isolation of anti-leukemia compounds from Citrus reticulata.

Authors:  N K Mak; Y L Wong-Leung; S C Chan; J Wen; K N Leung; M C Fung
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

9.  Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro.

Authors:  C Kandaswami; E Perkins; D S Soloniuk; G Drzewiecki; E Middleton
Journal:  Cancer Lett       Date:  1991-02       Impact factor: 8.679

10.  Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.

Authors:  S Tomozawa; H Nagawa; N Tsuno; K Hatano; T Osada; J Kitayama; E Sunami; M E Nita; S Ishihara; H Yano; T Tsuruo; Y Shibata; T Muto
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

View more
  9 in total

Review 1.  Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?

Authors:  Thomas Walle
Journal:  Semin Cancer Biol       Date:  2007-05-13       Impact factor: 15.707

2.  Chemopreventive effects of nobiletin and its colonic metabolites on colon carcinogenesis.

Authors:  Xian Wu; Mingyue Song; Minqi Wang; Jinkai Zheng; Zili Gao; Fei Xu; Guodong Zhang; Hang Xiao
Journal:  Mol Nutr Food Res       Date:  2015-10-07       Impact factor: 5.914

3.  Reduced angiogenesis in peritoneal dissemination of gastric cancer through gelatinase inhibition.

Authors:  Norihito Wada; Yoshihide Otani; Tetsuro Kubota; Masaru Kimata; Akiko Minagawa; Nobunari Yoshimizu; Kaori Kameyama; Yoshiro Saikawa; Masashi Yoshida; Toshiharu Furukawa; Masato Fujii; Koichiro Kumai; Yasunori Okada; Masaki Kitajima
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

4.  ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer.

Authors:  M F McCarty; A Takeda; O Stoeltzing; W Liu; F Fan; N Reinmuth; M Akagi; C Bucana; P F Mansfield; A Ryan; L M Ellis
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

5.  The citrus flavone nobiletin reduces pro-inflammatory and pro-labour mediators in fetal membranes and myometrium: implications for preterm birth.

Authors:  Carrington J Morwood; Martha Lappas
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

Review 6.  Chemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives?

Authors:  Santa Cirmi; Nadia Ferlazzo; Giovanni E Lombardo; Alessandro Maugeri; Gioacchino Calapai; Sebastiano Gangemi; Michele Navarra
Journal:  Nutrients       Date:  2016-11-04       Impact factor: 5.717

7.  Involvement of Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and the PI3K/AKT/mTOR Pathway in Nobiletin-Induced Apoptosis of Human Bladder Cancer Cells.

Authors:  Yih-Gang Goan; Wen-Tung Wu; Chih-I Liu; Choo-Aun Neoh; Yu-Jen Wu
Journal:  Molecules       Date:  2019-08-08       Impact factor: 4.411

8.  Chinese herbal medicine combined with oxaliplatin-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis of contributions of specific medicinal materials to tumor response.

Authors:  Ying Tan; Heping Wang; Bowen Xu; Xiaoxiao Zhang; Guanghui Zhu; Yuansha Ge; Taicheng Lu; Ruike Gao; Jie Li
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

9.  Matrix metalloproteinase inhibitor, marimastat, decreases peritoneal spread of gastric carcinoma in nude mice.

Authors:  Masaru Kimata; Yoshihide Otani; Tetsuro Kubota; Naoki Igarashi; Takeyoshi Yokoyama; Norihito Wada; Nobunari Yoshimizu; Masato Fujii; Kaori Kameyama; Yasunori Okada; Koichiro Kumai; Masaki Kitajima
Journal:  Jpn J Cancer Res       Date:  2002-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.